Literature DB >> 26581600

IL-17A promotes susceptibility during experimental visceral leishmaniasis caused by Leishmania donovani.

Cesar Terrazas1, Sanjay Varikuti2, Jennifer Kimble2, Ellen Moretti2, Prosper N Boyaka2, Abhay R Satoskar1.   

Abstract

Leishmania donovani is an intracellular parasite that infects professional phagocytes and causes visceral leishmaniasis (VL). The immune response during VL has been extensively studied in the context of T-helper (Th)1 and Th2 responses. Immunity against this parasite is dependent on IFN-γ production and subsequent macrophage activation, and the Th2 response promotes granuloma formation. The cytokine IL-17A is associated with neutrophilic inflammation. Depletion of neutrophils during experimental VL results in enhanced parasitic loads. Furthermore, although patients resistant to VL showed enhanced levels of IL-17A in circulation, little is known about the role of IL-17A during VL infection. Here, we used IL-17A-deficient mice and IL-17A reporter mice to address the role of IL-17A during VL. IL-17A(-/-) mice were highly resistant to VL infection, showing decreased parasites in the liver and spleen. This unexpected phenotype was associated with enhanced IFN-γ production by T cells and decreased accumulation of neutrophils and monocytes, resulting in reduced number of granulomas. We also found γδ T and Th17 cells as the main IL-17A(+) cells during VL infection. Our data reveal an unexpected role of IL-17A rendering susceptibility against L. donovani by regulating the IFN-γ response and promoting detrimental inflammation. © FASEB.

Entities:  

Keywords:  Th17; granuloma; monocytes; neutrophils; γδ T cells

Mesh:

Substances:

Year:  2015        PMID: 26581600      PMCID: PMC4750409          DOI: 10.1096/fj.15-277202

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  47 in total

1.  IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani.

Authors:  Maira G R Pitta; Audrey Romano; Sandrine Cabantous; Sandrine Henri; Awad Hammad; Bouréma Kouriba; Laurent Argiro; Musa el Kheir; Bruno Bucheton; Charles Mary; Sayda Hassan El-Safi; Alain Dessein
Journal:  J Clin Invest       Date:  2009-07-13       Impact factor: 14.808

2.  IL-13 is a susceptibility factor for Leishmania major infection.

Authors:  D J Matthews; C L Emson; G J McKenzie; H E Jolin; J M Blackwell; A N McKenzie
Journal:  J Immunol       Date:  2000-02-01       Impact factor: 5.422

3.  IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice.

Authors:  John S Cho; Eric M Pietras; Nairy C Garcia; Romela Irene Ramos; David M Farzam; Holly R Monroe; Julie E Magorien; Andrew Blauvelt; Jay K Kolls; Ambrose L Cheung; Genhong Cheng; Robert L Modlin; Lloyd S Miller
Journal:  J Clin Invest       Date:  2010-04-01       Impact factor: 14.808

4.  Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung.

Authors:  Yuko Okamoto Yoshida; Masayuki Umemura; Ayano Yahagi; Rebecca L O'Brien; Koichi Ikuta; Kenji Kishihara; Hiromitsu Hara; Susumu Nakae; Yoichiro Iwakura; Goro Matsuzaki
Journal:  J Immunol       Date:  2010-03-08       Impact factor: 5.422

5.  Uncovering Leishmania-macrophage interplay using imaging flow cytometry.

Authors:  Cesar Terrazas; Steve Oghumu; Sanjay Varikuti; Diana Martinez-Saucedo; Stephen M Beverley; Abhay R Satoskar
Journal:  J Immunol Methods       Date:  2015-05-09       Impact factor: 2.303

6.  IL-17-mediated monocyte migration occurs partially through CC chemokine ligand 2/monocyte chemoattractant protein-1 induction.

Authors:  Shiva Shahrara; Sarah R Pickens; Arthur M Mandelin; William J Karpus; Qiquan Huang; Jay K Kolls; Richard M Pope
Journal:  J Immunol       Date:  2010-03-12       Impact factor: 5.422

7.  IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice.

Authors:  Susanna Lopez Kostka; Stephanie Dinges; Klaus Griewank; Yoichiro Iwakura; Mark C Udey; Esther von Stebut
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

8.  Accelerated control of visceral Leishmania donovani infection in interleukin-6-deficient mice.

Authors:  Henry W Murray
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

9.  Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis.

Authors:  Yinyao Lin; Shane Ritchea; Alison Logar; Samantha Slight; Michelle Messmer; Javier Rangel-Moreno; Lokesh Guglani; John F Alcorn; Heather Strawbridge; Sang Mi Park; Reiko Onishi; Nikki Nyugen; Michael J Walter; Derek Pociask; Troy D Randall; Sarah L Gaffen; Yoichiro Iwakura; Jay K Kolls; Shabaana A Khader
Journal:  Immunity       Date:  2009-10-22       Impact factor: 31.745

10.  Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.

Authors:  Caroline E Sutton; Stephen J Lalor; Cheryl M Sweeney; Corinna F Brereton; Ed C Lavelle; Kingston H G Mills
Journal:  Immunity       Date:  2009-08-13       Impact factor: 31.745

View more
  18 in total

1.  Interleukin-17 mediated immunity during infections with Trypanosoma cruzi and other protozoans.

Authors:  María Carolina Amezcua Vesely; Constanza Rodríguez; Adriana Gruppi; Eva Virginia Acosta Rodríguez
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-01-24       Impact factor: 5.187

2.  Live Attenuated Leishmania donovani Centrin Gene-Deleted Parasites Induce IL-23-Dependent IL-17-Protective Immune Response against Visceral Leishmaniasis in a Murine Model.

Authors:  Antara Banerjee; Parna Bhattacharya; Pradeep K Dagur; Subir Karmakar; Nevien Ismail; Amritanshu B Joshi; Adovi D Akue; Mark KuKuruga; John Philip McCoy; Ranadhir Dey; Hira L Nakhasi
Journal:  J Immunol       Date:  2017-11-29       Impact factor: 5.422

3.  Gamma Interferon-Regulated Chemokines in Leishmania donovani Infection in the Liver.

Authors:  Henry W Murray; Andrew D Luster; Hua Zheng; Xiaojing Ma
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

Review 4.  Cytokines and Signaling Networks Regulating Disease Outcomes in Leishmaniasis.

Authors:  Amrita Saha; Souravi Roy; Anindita Ukil
Journal:  Infect Immun       Date:  2022-07-11       Impact factor: 3.609

5.  Comparison of serum cytokine levels in symptomatic and asymptomatic HIV-Leishmania coinfected individuals from a Brazilian visceral leishmaniasis endemic area.

Authors:  Diego Lins Guedes; Elis Dionísio da Silva; Maria Carolina Accioly Brelaz Castro; Walter Lins Barbosa Júnior; Ana Victoria Ibarra-Meneses; Achilleas Tsoumanis; Wim Adriaensen; Johan van Griensven; Valéria Rêgo Alves Pereira; Zulma Maria de Medeiros
Journal:  PLoS Negl Trop Dis       Date:  2022-06-17

6.  Human Interleukin-32γ Plays a Protective Role in an Experimental Model of Visceral Leishmaniasis in Mice.

Authors:  Leo A B Joosten; Fátima Ribeiro-Dias; Rodrigo Saar Gomes; Muriel Vilela Teodoro Silva; Jéssica Cristina Dos Santos; Christine van Linge; Juliana Machado Reis; Mauro Martins Teixeira; Sebastião Alves Pinto; Miriam Leandro Dorta; Xiyuan Bai; Edward D Chan; Charles A Dinarello; Milton Adriano Pelli Oliveira
Journal:  Infect Immun       Date:  2018-04-23       Impact factor: 3.441

Review 7.  Heterogeneity in the initiation, development and function of type 2 immunity.

Authors:  William C Gause; Carla Rothlin; P'ng Loke
Journal:  Nat Rev Immunol       Date:  2020-05-04       Impact factor: 53.106

8.  MicroRNA155 Plays a Critical Role in the Pathogenesis of Cutaneous Leishmania major Infection by Promoting a Th2 Response and Attenuating Dendritic Cell Activity.

Authors:  Sanjay Varikuti; Chaitenya Verma; Gayathri Natarajan; Steve Oghumu; Abhay R Satoskar
Journal:  Am J Pathol       Date:  2021-02-02       Impact factor: 4.307

9.  Evaluation of IL-12RB1, IL-12B, CXCR-3 and IL-17a expression in cases affected by a non-healing form of cutaneous leishmaniasis: an observational study design.

Authors:  Mohammad Moafi; Hossein Rezvan; Roya Sherkat; Roya Taleban; Ali Asilian; Seyed Hamid Zarkesh Esfahani; Mohammad Ali Nilforoushzadeh; Fariba Jaffary; Awat Feizi
Journal:  BMJ Open       Date:  2017-01-27       Impact factor: 2.692

Review 10.  The Equivocal Role of Th17 Cells and Neutrophils on Immunopathogenesis of Leishmaniasis.

Authors:  Suênia da C Gonçalves-de-Albuquerque; Rômulo Pessoa-E-Silva; Lays A M Trajano-Silva; Tayná Correia de Goes; Rayana C S de Morais; Cíntia N da C Oliveira; Virgínia M B de Lorena; Milena de Paiva-Cavalcanti
Journal:  Front Immunol       Date:  2017-10-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.